Inferior cancer survival for men with localized high-grade prostate cancer but low prostate-specific antigen
AuthorsFankhauser, Christian D
Gonzalez-Feliciano, A. G.
Clarke, Noel W
Stopsack, K. H.
Gerke, T. A.
Preston, M. A.
Mucci, L. A.
AffiliationDepartment of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland;
MetadataShow full item record
CitationFankhauser CD, Penney KL, Gonzalez-Feliciano AG, Clarke NW, Hermanns T, Stopsack KH, et al. Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen. Eur Urol. 2020.
- Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
- Authors: Aizer AA, Chen MH, Hattangadi J, D'Amico AV
- Issue date: 2014 Jan
- Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
- Authors: Ang M, Rajcic B, Foreman D, Moretti K, O'Callaghan ME
- Issue date: 2016 Apr
- Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigen.
- Authors: Falchook AD, Martin NE, Basak R, Smith AB, Milowsky MI, Chen RC
- Issue date: 2016 Mar
- Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer.
- Authors: Stroup SP, Moreira DM, Chen Z, Howard L, Berger JH, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ
- Issue date: 2017 Dec
- The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma.
- Authors: Wang J, Abudurexiti M, Shao N, Wei Y, Zhu Y, Ye DW
- Issue date: 2020 Jan 15